CNE100004S13
CNE100004S13
ACROBIOSYSTEMS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 20.43B EUR | 8.02B EUR | 7.32B EUR |
Enterprise Value | 19.45B EUR | 7.64B EUR | 6.62B EUR |
Valuation Multiples | |||
Trailing P/E | 113.15x | 45.93x | 44.85x |
Forward P/E | -- | -- | -- |
Price to Sales | 21.5x | 8.67x | 8.63x |
Price to Book | 7.69x | 3.02x | 2.71x |
EV/Revenue | 20.46x | 8.25x | 7.8x |
EV/EBITDA | 99.75x | 32.26x | 29.34x |
Price to FCF (P/FCF) | -- | 66.58x | 57.36x |
EV/FCF | -- | 63.37x | 51.87x |
FCF Yield | -0.82% | 1.5% | 1.74% |